Hepatogenic weakness as a clinical marker of hyperammonemia and of the effectiveness of its correction in patients with pre-cirrhotic stages of non-alcoholic fatty liver disease
The aim of this work was identification of markers of of hyperammonemia (HA) available in routine practice, and assessment of the effectiveness of ornithine in treatment of HA and its clinical manifestations in patients with NAFLD at the pre-cirrhotic stage.Outpatients with NAFLD with hepatic steato...
Gardado en:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Russo |
| Publicado: |
Open Systems Publication
2021-06-01
|
| Series: | Лечащий Врач |
| Assuntos: | |
| Acceso en liña: | https://journal.lvrach.ru/jour/article/view/173 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|